Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.
作者信息
Allen J M, Kerle D J, Ware H, Doble A, Williams G, Bloom S R
出版信息
Br Med J (Clin Res Ed). 1983 Dec 10;287(6407):1766. doi: 10.1136/bmj.287.6407.1766.
Abstract
摘要
相似文献
1
Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.
Br Med J (Clin Res Ed). 1983 Dec 10;287(6407):1766. doi: 10.1136/bmj.287.6407.1766.
2
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone.
Br Med J (Clin Res Ed). 1984 Aug 25;289(6443):468-9. doi: 10.1136/bmj.289.6443.468.
3
[Hormonal manipulation of disseminated prostatic cancer].
Acta Urol Belg. 1984;52(4):593-9.
4
Prostatic cancer: treatment with long-acting LHRH analogue.
Br J Urol. 1983 Dec;55(6):743-6. doi: 10.1111/j.1464-410x.1983.tb03417.x.
5
[New hormonal treatments of metastatic prostatic cancer. Review of the literature].
Rev Rhum Mal Osteoartic. 1985 Oct;52(10):577-85.
6
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1607-9. doi: 10.1136/bmj.286.6378.1607.
7
New treatment for prostatic cancer.
Lancet. 1983 Aug 20;2(8347):438.
8
Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms.
Lancet. 1983 Aug 20;2(8347):415-9. doi: 10.1016/s0140-6736(83)90387-2.
9
Endocrine therapy: non-estrogenic pharmacological manipulation.
Semin Urol. 1983 Nov;1(4):288-90.
10
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma.
Lancet. 1983 Aug 20;2(8347):413-5. doi: 10.1016/s0140-6736(83)90386-0.
引用本文的文献
1
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.
Clin Cancer Res. 2014 Dec 15;20(24):6269-76. doi: 10.1158/1078-0432.CCR-14-1595. Epub 2014 Oct 21.
2
Flare Associated with LHRH-Agonist Therapy.
Rev Urol. 2001;3 Suppl 3(Suppl 3):S10-4.
3
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Urol Res. 1984;12(5):249-51. doi: 10.1007/BF00256149.
4
Treatment of advanced carcinoma of the prostate.
Br Med J (Clin Res Ed). 1984 Sep 8;289(6445):571-2. doi: 10.1136/bmj.289.6445.571.
5
Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.
J Clin Pathol. 1985 Jun;38(6):677-8. doi: 10.1136/jcp.38.6.677.
6
GnRH agonists and antagonists. Current clinical status.
Drugs. 1988 Jan;35(1):63-82. doi: 10.2165/00003495-198835010-00004.
7
Hormonal aspects of prostatic cancer: a review.
J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.
8
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
Br J Cancer. 1988 Oct;58(4):493-6. doi: 10.1038/bjc.1988.247.
本文引用的文献
1
Ketoconazole: a novel and rapid treatment for advanced prostatic cancer.
J Urol. 1983 Jul;130(1):152-3. doi: 10.1016/s0022-5347(17)51007-1.
2
Ketoconazole blocks testosterone synthesis.
Arch Intern Med. 1982 Nov;142(12):2137-40.
3
Ketoconazole blocks adrenal steroid synthesis.
Ann Intern Med. 1982 Sep;97(3):370-2. doi: 10.7326/0003-4819-97-3-370.
4
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1607-9. doi: 10.1136/bmj.286.6378.1607.
Zotero 插件